Switching to aripiprazole for the treatment of residual mutism resulted in distinct clinical courses in two catatonic schizophrenia cases

OBJECTIVES: The efficacy of a partial agonist for the dopamine D(2) receptor, aripiprazole, for catatonia in schizophrenia has been reported. METHODS: We report distinct clinical courses in challenging aripiprazole to treat residual mutism after severe catatonic symptoms improved. RESULTS: In the fi...

Full description

Saved in:
Bibliographic Details
Published in:SAGE Open Med Case Rep
Main Authors: Muneoka, Katsumasa, Kanahara, Nobuhisa, Kimura, Shou
Format: Artigo
Language:Inglês
Published: SAGE Publications 2017
Subjects:
Case Report
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5315413/
https://ncbi.nlm.nih.gov/pubmed/28255444
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2050313X17692936
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items